METHOD FOR IN VITRO DETECTION AND IDENTIFICATION OF ONE OR MORE MICROORGANISMS INVOLVED IN THE DEGRADATION, MODIFICATION OR SEQUENCING PROCESS OF ONE OR MORE CONTAMINANTS PRESENT IN A BIOLOGICAL SAMPLE
FR3055339A1
METHOD FOR IN VITRO DETECTION AND IDENTIFICATION OF ONE OR MORE TARGET PATHOGENS PRESENT IN A BIOLOGICAL SAMPLE
CN104918633A
Use of microorganisms for reducing the level of trimethylamine in a human body cavity, in particular for the treatment of trimethylaminuria or of bacterial vaginosis and the prevention of cardiovascular diseases
FR3003169A1
USE OF MICROORGANISMS TO DECREASE THE TRIMETHYLAMINE RATE IN A HUMAN BODY CAVITY, IN PARTICULAR FOR THE TREATMENT OF TRIMETHYLAMINURIA OR BACTERIAL VAGINOSIS AND THE PREVENTION OF CARDIOVASCULAR DISEASES
FR2998799A1
USE OF MICROORGANISMS TO DECREASE TRIMETHYLAMINE RATE IN INTESTINES, TREATMENT OF TRIMETHYLAMINUREMIA AND PREVENTION OF ATHEROMIC PLATE FORMATION
FR2985667A1
AQUEOUS LOCK COMPOSITION COMPRISING ETHANOL AND A POLYSACCHARIDE ANTICOAGULANT
FR2984920A1
In vitro method of predicting/diagnosing risk of developing multifactorial diseases includes detecting presence/absence of genic marker of multifactorial disease and environmental marker in sample and comparing results with reference value
FR2980196A1
ACTIVE ANTICANCER PRINCIPLE ISSUED FROM GUIERA SENEGALENSIS
FR2967868A1
USE OF A FOOD COMPOSITION IN THE TREATMENT AND / OR PREVENTION OF NEUROPATHIC PAIN INDUCED BY AN ANTICANCER AGENT
FR2965812A1
COATING FOR CONTAINERS, IN PARTICULAR PLASTIC SOFT MATERIAL
EP2377883A1
Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease
FR2957077A1
USE OF RILUZOLE FOR TREATING OR PREVENTING ADVERSE EFFECTS OF ANTI-CANCER AGENTS
CA2711622A1
Non invasive method for detecting an electric parameter depending on the intralabyrinth pressure (pil) in a subject
